Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
Researchers compared Asenapine, Haloperidol and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared asenapine, placebo and olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers compared asenapine, placebo and Olanzapine to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedResearchers are comparing AVE1625 and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.
This study ended early.
Multiple locations, including BridgewaterThis study evaluated the effectiveness of Celecoxib for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including La PlataThis study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixEfficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer's Disease.
This study has finished and is no longer accepting participants.
Location not clearly listedThis study evaluated the safety and effectiveness of risperidone oral solution for people with schizophrenia.
This study has finished and is no longer accepting participants.
In ChangshaResearchers studied Quetiapine XR (Seroquel XR) to find out how it affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Johor BahruResearchers compared ABT-288 Low Dose, ABT-288 High Dose and placebo to find out how the approaches affected memory, attention and other thinking skills in people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including AnaheimCorrelation of Phenotype, Genotype and Clinical Efficacy/Toxicity of Clozapine Augmented by Atomoxetine for Treatment Refractory Schizophrenia (CAPG Study)
This study ended early.
In IndianapolisResearchers compared iloperidone and Risperidone to find out how the approaches affected psychotic symptoms in people with schizophrenia.
This study has finished and is no longer accepting participants.
In BeijingWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.